Treatment of circulating CD34+ cells with SDF-1α or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential
Experimental Hematology2002Vol. 30(9), pp. 1061–1069
Citations Over TimeTop 10% of 2002 papers
P. Artur Plett, Stacy M. Frankovitz, Frances M. Wolber, Rafat Abonour, Christie M. Orschell-Traycoff
Related Papers
- → Modulating the Interaction of Stromal-cell-derived Factor-1/CXCL12 and its Receptor, CXCR4, for Enhanced Mobilisation, Homing and Engraftment of Haematopoietic Stem Cells(2007)1 cited
- → Ultrasound-Targeted Microbubble Destruction Improves the Migration and Homing of Mesenchymal Stem Cells after Myocardial Infarction by Upregulating SDF-1/CXCR4: A Pilot Study(2015)53 cited
- → Homing in hematopoietic stem cells: focus on regulatory role of CXCR7 on SDF1a/CXCR4 axis(2016)47 cited
- → CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency(2017)12 cited
- → Lymphocyte phenotyping and NK cell activity analysis in pregnant NOD/SCID mice(2005)38 cited